Table 5.
Comparison of characteristics between survivals and deaths
| Survivors(n = 39) | Deaths (n = 7) | p value | |
|---|---|---|---|
| Age | 62 (22, 85) | 68 (55, 78) | 0.668 |
| Gender | |||
| Male | 30 (76.9) | 6 (85.7) | 1.000 |
| Female | 9 (23.1) | 1 (14.3) | |
| Underlying disease | |||
| Viral hepatitis | 13 (33.3) | 5 (71.4) | 0.093 |
| Liver cirrhosis | 4 (10.2) | 4 (57.1)* | 0.012 |
| Chronic liver dysfunction | 13 (33.3) | 6 (85.7)* | 0.015 |
| Diabetes mellitus | 16 (41.0) | 2 (28.6) | 0.688 |
| Chronic renal failure | 5 (12.8) | 4 (57.1)* | 0.020 |
| Immunocompromised(DM, liver dysfunction, CRF, malignancy) | 27 (69.2) | 7 (100) | 0.165 |
| Pathogens | |||
| Gram positive pathogen | 10 (25.6) | 1 (14.3) | 0.667 |
| Gram negative pathogen | 29 (74.4) | 6 (85.7) | |
| Involved region | |||
| Upper extremity | 11 (28.2) | 4 (57.1) | 0.193 |
| Lower extremity | 28 (71.8) | 3 (42.9) | |
| Shock at ER | 19 (48.7) | 6 (85.7) | 0.106 |
Data are presented as median (min, max) or frequency (%)
Chronic liver dysfunction: liver cirrhosis, viral hepatitis (HBV, or HCV)
*: The difference is significant (p < 0.05)